Výsledky vyhledávání - "Emeline Guiard"

Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma

Autor: Audrey Rambeau, Elodie Vauleon, Marion Perréard, Emeline Guiard, Alison Claire Johnson, Caroline Even, Cyril Abdeddaim, Florian Clatot

Publikováno v: European Journal of Cancer. 159:125-132

Background Immune checkpoint inhibitors are widely used in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). We aimed to describe response rates to taxanes after progression on nivolumab in R/M HNSCC patients. Methods In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7c4ff0c9ff551d63fb3e3808f3332a
https://doi.org/10.1016/j.ejca.2021.09.025

Zobrazit plný text záznamu

Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs

Autor: Emeline Guiard, Capucine Baldini, Cédric Pobel, Tarek Assi, Alice Bernard-Tessier, Patricia Martin-Romano, Antoine Hollebecque, Loïc Verlingue, Arthur Geraud, Jean-Marie Michot, Jean-Pierre Armand, Jean-Charles Soria, Christophe Massard, Samy Ammari

Publikováno v: European journal of cancer (Oxford, England : 1990). 167

Immune checkpoint blockers (ICBs) in combination with antiangiogenic drugs showed synergistic efficacy in several tumour types. New patterns of progression have recently been defined upon treatment with ICB alone including atypical responses such as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12f9469288c9377a77114072243a11a
https://pubmed.ncbi.nlm.nih.gov/35378410

Zobrazit plný text záznamu

Taxanes plus cetuximab with or without platinum chemotherapy after progression on immune checkpoint inhibitors in patients with squamous cell carcinoma of the head and neck

Autor: Khalil Saleh, Marie Vinches, Inga Safta, Emeline Guiard, Gregoire Marret, Roman Vion, Joel Guigay, François-Régis Ferrand, Florian Clatot, Christophe Le Tourneau, Audrey Rambeau, Esma Saada-Bouzid, Amaury Daste, Caroline Even

Publikováno v: Journal of Clinical Oncology. 40:6036-6036

6036 Background: Salvage chemotherapy after progression on immune checkpoint inhibitors (ICIs) was associated with an objective response rate (ORR) of 30% in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::99bea2c493e44a44b06ed1a2cf980d10
https://doi.org/10.1200/jco.2022.40.16_suppl.6036

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání